May 01, 2020 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Merck (MRK) have what it takes? Let's find out.
Apr 28, 2020 - Merck & Co., Inc. (NYSE:MRK) Q1 2020 Results Earnings Conference Call April 28, 2020 08:00 AM ET Company Participants Peter Dannenbaum - Vice President, Investor Relations Ken Frazier - Chairman a
Apr 28, 2020 - MRK earnings call for the period ending March 31, 2020.
Apr 28, 2020 - Earnings Data Deluge
Apr 28, 2020 - A big morning for Q1 earnings reports joins a new Advance Trade in Goods report out this morning. Pre-market indexes are way in the green at this hour.
Apr 27, 2020 - Let us take a look at three big drug companies due to release their first-quarter financial results on Apr 28.
Apr 24, 2020 - In Pfizer's (PFE) Biopharma unit, oncology sales are likely to have risen in the first quarter, while in non-oncology, Xeljanz and Eliquis alliance revenues are likely to have supported the top line.
Apr 20, 2020 - Roche's (RHHBY) newer drugs are likely to have combated the biosimilar competition for legacy drugs in the first quarter.
Apr 20, 2020 - Incyte (INCY) gets FDA approval for Pemazyre for the treatment of previously-treated, unresectable, locally-advanced or metastatic cholangiocarcinoma.
Apr 17, 2020 - The FDA accepts Regeneron's (REGN) BLA for REGN-EB3 under a priority review to treat the deadly Ebola virus infection. A verdict is pending on Oct 25, 2020.